Vor Biopharma, Inc. (VOR)
10.30
-0.42
(-3.87%)
USD |
NASDAQ |
Dec 10, 16:00
10.16
-0.14
(-1.41%)
After-Hours: 20:00
Vor Biopharma EPS Diluted (Quarterly): -121.63 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Outset Medical, Inc. | -1.003 |
| Salarius Pharmaceuticals, Inc. | -1.814 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -812.68M |
| Total Expenses (Quarterly) | 812.68M |
| Enterprise Value | -94.07M |
| Earnings Yield | -3.71K% |
| Normalized Earnings Yield | -1492.68 |